Vicore has announced its intention to acquire INIM Pharma AB, a private Swedish biotech company focused on severe rare lung diseases, through a share issue that will lead to INIM's majority shareholder and leading VC firm HealthCap becoming Vicore's largest shareholder. In connection with the acquisition, Vicore's Board of Directors proposes a SEK80m rights issue and the distribution of the majority of Vicore's shareholding in recently listed I-Tech to current shareholders ahead of the acquisiti ....
03 Jul 2018
Acquisition of INIM brings HealthCap on board
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Acquisition of INIM brings HealthCap on board
Vicore Pharma Holding AB (6Y4:FRA) | 0 0 0.0%
- Published:
03 Jul 2018 -
Author:
Brigitte de Lima, PHD CFA -
Pages:
5
Vicore has announced its intention to acquire INIM Pharma AB, a private Swedish biotech company focused on severe rare lung diseases, through a share issue that will lead to INIM's majority shareholder and leading VC firm HealthCap becoming Vicore's largest shareholder. In connection with the acquisition, Vicore's Board of Directors proposes a SEK80m rights issue and the distribution of the majority of Vicore's shareholding in recently listed I-Tech to current shareholders ahead of the acquisiti ....